(PharmaNewsWire.Com, January 28, 2022 ) According to the new market research report, "Intraoperative Imaging Market by Product (Mobile C-arms, CT, Intraoperative MRI, Ultrasound, X ray), Application (Neurosurgery, Orthopedic & Trauma Care, Spine, CVDs, ENT, Gastroenterology), Enduser (Hospitals, ASCs, Academia)- Forecasts to 2025" The global intraoperative imaging market size is estimated to be USD 1.9 billion in 2020 and projected to reach USD 2.5 billion by 2025, at a CAGR of 5.2 %.
Browse and in-depth TOC on "Intraoperative Imaging Market"
Increasing prevalence of diseases and disorders, technological advancements and increased funding and public-private investments are the key factors driving the growth of the intraoperative imaging.
The intraoperative imaging market includes major Tier I and II suppliers like General Electric Company (US), Siemens Healthineers AG (Germany), Canon (Japan), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands), IMRIS (US) and Shimadzu Corporation (Japan). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for intraoperative imaging from key end-users has declined a bit amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have short-term decline in the growth for the intraoperative imaging market in 2020, but will experience normal growth as the market gradually steadies by the end of 2020.
Demand for mobile c arm result in the segment occupying the high share of the intraoperative imaging market
Mobile C-arms are medical imaging devices that comprise a generator, the X-ray source, and an image intensifier or flat-panel detector. The X-rays emitted by the generator penetrate the patient’s body and are then converted into visible images by the image intensifiers or detectors before being displayed on the monitor. The C-shaped connecting element allows movement in three axes, allowing for imaging across a wide range of angles. The growing demand for mobile C-arms is mainly attributed to their broadening application horizons. For instance, C-arms are used for a wide range of applications, including cardiovascular surgeries, neurosurgeries, gastroenterology surgeries, orthopedics, traumatology, and urology disorders.
In the coming years, the demand for spinal surgeries is expected to grow significantly owing to the increasing incidence of various target diseases/disorders such as osteoporosis, spine stenosis, spinal trauma/spinal cord injury (SCI), metastatic spinal tumors, and multiple myeloma. Procedures such as lumbar discectomies and posterior cervical foraminotomy are commonly performed on an outpatient basis. This increases access to spine surgery and can be expected to support the demand for advanced technologies in the coming years.
Asia Pacific likely to emerge as the fastest growing intraoperative imaging market, globally
Geographically, the emerging Asian countries, such as China, India, South Korea, Taiwan, and Singapore, are offering high-growth opportunities for market players. The Asia Pacific intraoperative imaging market is projected to grow at the highest CAGR of 6.4% from 2020 to 2025. Government efforts to increase fundings; supportive regulations for the development and commercialization of advanced intraoperative imaging products; rising healthcare expenditure; the increasing number of hospitals in India and China; expanding research base across India, China, and Japan; and the increasing incidence of surgeries are driving the growth of the APAC intraoperative imaging market.
Prominent players in this market General Electric Company (US), Siemens Healthineers AG (Germany), Ziehm Imaging GmbH (Germany), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands) were the top five players in the global intraoperative imaging market. Other notable companies are Canon Healthcare (Japan), Stryker (US), Brainlab AG (Germany), IMRIS (US), Shimadzu Corporation (Japan), Shenzhen Anke High-tech Co. (China), Hitachi, Ltd. (Japan), FUJIFILM Holdings (Japan), Carl Zeiss Meditec AG (Germany), Mindray Ltd. (US), Carestream Health (US), Analogic Corporation (US), Allengers Medical Systems Ltd. (India), Esaote SpA (Italy) and NeuroLogica Corporation (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: